The opportunity cost of androgen suppression in locally advanced prostate cancer. [electronic resource]
- Asian journal of andrology May 2013
- 356-7 p. digital
Publication Type: Journal Article; Comment
1745-7262
10.1038/aja.2012.166 doi
Adenocarcinoma--therapy Androgen Antagonists--therapeutic use Antineoplastic Agents, Hormonal--therapeutic use Bone Density Conservation Agents--therapeutic use Brachytherapy Diphosphonates--therapeutic use Humans Imidazoles--therapeutic use Leuprolide--therapeutic use Male Prostatic Neoplasms--therapy Quality of Life